New app aims to boost black Women's role in breast cancer research
NCT ID NCT06361056
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tested a mobile health app designed to help Black women with breast cancer learn about clinical trials and decide whether to join. Eighty Black women with newly diagnosed breast cancer who had a smartphone or computer took part. The app provided education and a way to communicate with their care team. Researchers measured how many women completed the study and how satisfied they were.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
mHealth app
What this could lead to
If successful, this app could help more Black women learn about and join breast cancer clinical trials, making research more inclusive.
What could go wrong
This is a small, completed feasibility study with 80 participants, so it cannot prove the app improves trial participation. Results may not apply to all Black women.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UNC Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, 27514, United States